CompletedPhase 2NCT00005088
Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
Studying Squamous cell carcinoma of head and neck
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Radiation Therapy Oncology Group
- Principal Investigator
- K. Kian Ang, MD, PhDM.D. Anderson Cancer Center
- Intervention
- cisplatin(drug)
- Eligibility
- 0-120 years · All sexes
- Timeline
- 2000
Study locations (30)
- University of Alabama Comprehensive Cancer Center, Birmingham, Alabama, United States
- Comprehensive Cancer Institute of Huntsville, Huntsville, Alabama, United States
- Huntsville Hospital System, Huntsville, Alabama, United States
- Mobile Infirmary Medical Center, Mobile, Alabama, United States
- Urology Associates - Mobile AL, Mobile, Alabama, United States
- MBCCOP - University of South Alabama, Mobile, Alabama, United States
- Alabama Oncology, LLC, Montgomery, Alabama, United States
- Radiation Oncology Associates of West Alabama, Tuscaloosa, Alabama, United States
- Providence Cancer Therapy Center, Anchorage, Alaska, United States
- Arizona Cancer Center, Tucson, Arizona, United States
- Mount Diablo Medical Center, Concord, California, United States
- California Cancer Center, Fresno, California, United States
- Saint Agnes Cancer Center, Fresno, California, United States
- Glendale Memorial Hospital and Health Center, Glendale, California, United States
- Sutter Health Western Division Cancer Research Group, Greenbrae, California, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00005088 on ClinicalTrials.govOther trials for Squamous cell carcinoma of head and neck
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07333274Compare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible Patients With Locoregionally Advanced Head and Neck Squamous Cell CarcinomaShandong Cancer Hospital and Institute
- RECRUITINGPHASE3NCT07026474Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSCCUniversität des Saarlandes
- RECRUITINGPHASE1NCT07182149A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid TumorsNormunity AccelCo, Inc.
- RECRUITINGNANCT07203911Surgeon-performed Ultrasound for Real-time Guidance In Oral Cancer Surgeries - A Multicenter Randomized Controlled TrialTobias Todsen
- RECRUITINGNANCT07180901Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck CancerCentre hospitalier de l'Université de Montréal (CHUM)
- ACTIVE NOT RECRUITINGEARLY PHASE1NCT07435415Local Injection Methylene Blue Combined With Radiation in HNSCC PatientsChina Medical University Hospital
- RECRUITINGPHASE2NCT07088211Sacituzumab Tirumotecan and Toripalimab in the First-line Treatment of HNSCCShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- RECRUITINGPHASE2NCT07040956A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients.West China Hospital
See all trials for Squamous cell carcinoma of head and neck →